造血生态系统中的表观遗传修饰:从恒常状态到急性髓性白血病的关键调器
Shuxin Yao1,2,3, Rongxia Guo4, Wen Tian1,2,3
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China.
Blood science (Baltimore, Md.)
|September 16, 2024
概括
DNA甲基化和RNA m6A的修饰对于调节造血干细胞 (HSC) 和急性髓性白血病 (AML) 的发展至关重要. 了解这些表观遗传变化对于推动AML研究和治疗策略至关重要.
科学领域:
- 表观遗传学和血液形成
- 癌症生物学和分子瘤学
背景情况:
- 造血干细胞 (HSC) 通过复杂的调节机制维持血液系统的平衡.
- 急性髓性白血病 (AML) 是一种严重的血液性恶性瘤,其特点是遗传和表观遗传改变导致白血病干细胞 (LSC) 转变.
研究的目的:
- 阐明DNA甲基化和N6-甲基氨酸 (m6A) RNA修饰在正常血液形成和AML病变发生中的作用.
- 在AML的背景下,审查了解这些表观遗传修饰的最新进展.
主要方法:
- 对现有文献的审查,重点是DNA甲基化和m6ARNA修饰.
- 分析这些修改对HSC,LSC和AML发展的影响.
主要成果:
- 在AML中,DNA甲基化基因的体质突变很常见,导致广泛的DNA甲基化改变,从而引发AML.
- RNA m6A 修改对于造血细胞生态系统的生成和维护至关重要,它们的重编程对于AML的进展至关重要.
- 改变的DNA甲基化和m6A修饰是AML病变发生的关键驱动因素.
结论:
- DNA甲基化和m6ARNA修饰是正常血液形成和AML的基本表观遗传调节剂.
- 对这些修饰的全面理解对于开发有效的AML治疗策略至关重要,因为AML的发病过程复杂,预后不佳.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Histone Modification
13.2K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.2K


